Form 4/A for CRL Charles River Laboratories
Accepted 2024-03-25 00:00:00 ET · period of report 2024-01-29 · accession 0001127602-24-011094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-03-25 | 2024-01-29 | CRL | Knell Michael Gunnar | CAO, CSVP | A - Grant | $0.00 | +948 | 10.9K | +10% | $0 |
| A | 2024-03-25 | 2024-01-29 | CRL | Knell Michael Gunnar | CAO, CSVP | F - Tax | $220.28 | -313 | 10.6K | -3% | -$68.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | A | A | 948 | $0.00 | 10,888 | D | — | — | (F1) Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. |
| 2 | Common | Common Stock | 2024-01-29 | F | D | 313 | $220.28 | 10,575 | D | — | — |